Merint Molecular Imaging Private Limited - Company Profile

It is a real estate private limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Merint Molecular Imaging Private Limited

Merint Molecular Imaging Private Limited, a active private limited company, was established on 02 August 2006 in Mumbai, Maharashtra, India. Engaging in real estate leasing within the real estate sector, it holds CIN: U74999MH2006PTC163467. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹2.10 Cr and a paid-up capital of ₹2.03 Cr.

It upholds a compliant status. Its leadership includes Sukoon Akshay Sethi (Director), Fazal Mahemood Kassam Ali Manekia (Director). Past directors included Sukoon Akshay Sethi, Salma Fazal Manekia, Rakeshkumar Jatashankar Pathak. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Diagod,Offcarterroad,Sherlyrajanroad,Bandra(West),, Mumbai, Maharashtra, 400050.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2006PTC163467

  • Registration Number

    163467

  • Incorporation Date

    02 August 2006

  • Authorized Capital

    ₹2.10 Cr

  • Paid-Up Capital

    ₹2.03 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.10 Cr
  • Paid Up Capital ₹ 2.03 Cr
  • Company Age 19 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 123.93%
  • Ebitda **** 44.92%
  • Net Worth 0.38%
  • Total Assets **** 0.41%
Company report

Merint Molecular Imaging Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Merint Molecular Imaging Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Merint Molecular Imaging Private Limited?
Current Directors
Name Designation Appointment Date Status
Sukoon Akshay Sethi Director 10 Sep 2012 Current
Fazal Mahemood Kassam Ali Manekia Director 02 Aug 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2012 Past
Pramod Abcsdd Director 04 Sep 2016 Past
Pramod Abcsdd Director 19 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Merint Molecular Imaging.

Merint Molecular Imaging Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 123.93% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.

Merint Molecular Imaging revenue growth over time
Merint Molecular Imaging profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 0.41%
*******
*******
*******
*******
Profit or Loss
*******
 123.93%
*******
*******
*******
*******
Net Worth
*******
 0.38%
*******
*******
*******
*******
EBITDA
*******
 44.92%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Merint Molecular Imaging?

In 2017, Merint Molecular Imaging had a promoter holding of 72.37% and a public holding of 27.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Merint Molecular Imaging?

Unlock and access historical data on people associated with Merint Molecular Imaging, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Merint Molecular Imaging, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merint Molecular Imaging's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Merint Molecular Imaging
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Merint Molecular Imaging Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Merint Molecular Imaging Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    The activity Sukoon Akshay Sethi was appointed as a Director was appointed as a Director on 10 Sep 2012 & has been associated with this company since 13 years 5 months . was completed.

  • Director Appointment

    Fazal Mahemood Kassam Ali Manekia was appointed as a Director was appointed as a Director on 02 Aug 2006 & has been associated with this company since 19 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Merint Molecular Imaging Private Limited was registered on 02 Aug 2006 with Roc Mumbai I & aged 19 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Merint Molecular Imaging Private Limited?

The CIN of Merint Molecular Imaging Private Limited is U74999MH2006PTC163467.

Where is Merint Molecular Imaging Private Limited headquartered?

Merint Molecular Imaging Private Limited is headquartered at Diagod,Offcarterroad,Sherlyrajanroad,Bandra(West),, Mumbai, Maharashtra, 400050.

When was Merint Molecular Imaging Private Limited incorporated?

Merint Molecular Imaging Private Limited was incorporated on 02 August 2006.

Who are the current directors of Merint Molecular Imaging Private Limited?

The current directors of Merint Molecular Imaging Private Limited are

What is the primary industry of Merint Molecular Imaging Private Limited?

The primary industry of Merint Molecular Imaging Private Limited is Real Estate.

Is Merint Molecular Imaging Private Limited a listed company?

Merint Molecular Imaging Private Limited is unlisted.

What is the capital structure of Merint Molecular Imaging Private Limited?

The authorized capital of Merint Molecular Imaging Private Limited is ₹2.10 Cr, and the paid-up capital is ₹2.03 Cr.

What is the compliance status of Merint Molecular Imaging Private Limited?

The compliance status of Merint Molecular Imaging Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available